Azilsartan (medoxomil monopotassium) rdipine Hydrochloride pantothenate

pantothenate

KB-R7943 produced more pronounced inhibition of caffeine-induced Ca2+ release elicited by 1 mM compared with 0

16(22)23)13(18)6-10-20(14

while cinnarizine reduces their vasodilator effects[1]

Sodium sivelestat

Azilsartan (medoxomil monopotassium) rdipine Hydrochloride pantothenateAzilsartan medoxomil is a prodrug, is hydrolyzed to azilsartan in the gastrointestinal tract during absorption. Azilsartan is a selective AT1 subtype angiotensin II receptor antagonist. Azilsartan blocks the vasoconstrictor and aldosteronesecreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in many tissues, such as vascular smooth muscle and the adrenal gland. Its action is, therefore,